Aptus Pharma Board Approves ₹51 Crore Fund Raising For Expansion

Board approved a fundraise of up to 51 Cr for business expansion. The funding consists of a 35 Cr preferential allotment, 10 Cr in debt, and 6 Cr via internal accruals. The Managing Director was authorized to finalize investors. The proposal is subject to shareholder and regulatory approvals.